chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approx 24 hrs. after receiving vaccines patient vomited x 1, collapsed, became unresponsive. Intubated and worked up in ER. Transferred to Hosp. PICU x 2 days. Diagnosed as complex seizure. Unsure if related to vaccines. Positive family Hx of seizure disorder. Patient had no Hx of fever.
Patient reports he had a sore arm after receiving the vaccine, and that his arm is still sore (3 months later).
Received DTaP, MMR 12/18/07. This AM Mom noticed (L) arm swollen, red circle size of fist - swollen to elbow - feels hot to touch. No Tylenol/Motrin or cold compresses at this time.
A consumer report  has been received. The report concerns a 20 year old, male consumer, who had been receiving nasal FLUMIST Quadrivalent. FLUMIST Quadrivalent started on an unknown date. The patient experienced tested positive for influenza A mutated. The outcome of the event of tested positive for influenza A mutated is unknown. The report was considered to be non-serious.
Arm hurts; pain; Tired; she had a red rash that is lifted up a bit; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Arm hurts), PAIN (pain), FATIGUE (Tired) and RASH (she had a red rash that is lifted up a bit) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history  ).    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Arm hurts), PAIN (pain), FATIGUE (Tired) and RASH (she had a red rash that is lifted up a bit). At the time of the report, LIMB DISCOMFORT (Arm hurts), PAIN (pain), FATIGUE (Tired) and RASH (she had a red rash that is lifted up a bit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Slight soreness in right arm. Headache (which lasted 2 days), nausea, muscles aches, fatigue (which lasted 12 hours or so).
10/22 I went on a flight, and I had hives that appeared by Monday morning they got so bad I had to go to a doctor. I went to an urgent care, and they gave me Percocet 10mgs to take daily and anti-inflammatory, it was the same as Pepcid. They also prescribed Allegra for 5 days. It took about 3 days to lower the inflammation and it took about a week for the scaling to go away. You can still see the scabs as of now. I'm still dealing with the discoloration of the skin, but the discomfort is gone.
Patient reported dizziness, swelling, nausea, and paleness after 1-st dose of pfizer vaccine. Patient assess given water, Benadryl, ice pack, and monitored for an additional 15 minutes. Patient reported feeling better after approximately 10 minutes. After the wait time, the patient and patient's mother reported they felt ok to go home and would be ok with us following up with a call tomorrow.
acute onset of numbness/tingling (paresthesia) and weakness involving his left upper extremity, as well as gait instability from weakness involving the left lower extremity (difficulty ambulating).  He also endorses bilateral shoulder pain and neck pain.
Then it came back/ now the double vision is back; after her second dose her double vision associated with graves eyes disease got better for 6 months; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (after her second dose her double vision associated with graves eyes disease got better for 6 months) and DIPLOPIA (Then it came back/ now the double vision is back) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001821A and 025L20A) for COVID-19 vaccination.     The patient's past medical history included Polymyalgia rheumatica (PMR seemed not to go away completely, but numbers were high normal) in September 2015, Polymyalgia rheumatica in 2000 and Double vision (double vision associated with graves eyes disease). Concurrent medical conditions included Fruit allergy (Raspberry), Sulfonamide allergy (Sulfa drugs), Drug allergy (Metronidazole), Drug allergy (Rhopressa), Drug allergy (Alphagan Ophthalmic Solution), Hyperthyroidism (Start date: 2018-2019, Recent change in status: Normal) and Graves' disease (Start date: 2018-2019).   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 100 microgram. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 100 microgram. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (after her second dose her double vision associated with graves eyes disease got better for 6 months) and DIPLOPIA (Then it came back/ now the double vision is back). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (after her second dose her double vision associated with graves eyes disease got better for 6 months) outcome was unknown and DIPLOPIA (Then it came back/ now the double vision is back) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.   Patient's height was reported as 5.6.  Patient had neither tested nor diagnosed with COVID in the past.  No other vaccines were given within 1 month prior to Moderna COVID-19 vaccine.  AE caused patient to seek medical care. Doctors were amazed that her double vision went away.  No treatment details were reported.
Pyrexia 37.2 degrees C; Arthralgia; Malaise; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: was not reported), via an unspecified route of administration, administrated in left arm on 30Apr2021 09:30 (age at the time of vaccination 40-years-old), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient had no known allergies. Patient previously received first dose of BNT162B2 vaccine, on an unspecified date for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 01May2021 12:00, the patient experienced Pyrexia 37.2 degrees C, Arthralgia, and Malaise. On an unspecified date, the patient underwent lab tests and procedures which included Pyrexia, Body temperature: 37.2 degrees Centigrade. Patient did not received treatment for adverse events. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Chills, no manually detected fever (not measured with thermometer); time course approx 5P-2AM (11/10/2012); treatment=cover w/3 blankets & robe.
Flu like symptoms including nausea, chills generalized pain, headache and neck ache. Severe symptoms for 2 days. By day 4 symptoms resolved. Arm pain was expected. I have never reacted to any vaccine in the past to this degree.
Information has been received from a healthcare worker referring to an unspecified number of patients of unknown age. Concurrent conditions and medical history of the patient were not reported. On unknown dates, the patients were vaccinated with doses of improperly stored RECOMBIVAX HB (lot# J013394, expiry date 25-AUG-2016; lot# K010216, expiry date 17-SEP-2016; lot# K010535, expiry date 27-AUG-2016; lot# K018180, expiry date 17-SEP-2016; lot# K021444, expiry date 17-SEP-2016; lot# L004757 (invalid), expiry date 10-NOV-2016; lot# L016427, expiry date 13-APR-2017; lot# L018501, expiry date 22-JUN-2017; lot# L025738, expiry date 14-AUG-2017) (dose, route unspecified). Concomitant therapies were not reported. No adverse effect were reported. This is one of several reports received from the same source. Additional information has been requested.
Enlarged lymph node in armpit.  Rash starting on the back of my neck, left side.  Running down my arm into my armpit on left side only. Extending to the middle of my back. Not itchy at all.
A non-serious spontaneous case of FluMist administered to a nine-month-old was received from a registered nurse concerning a nine-month-old infant. There was no adverse event associated with vaccination error therefore, treatment and causality assessments are not applicable, and the event is considered resolved. This case is submitted in accordance with MedImmune's post-marketing committment on accelerated reporting for the newly indicated population of 2 years to 59 months of age for FluMist.
21 year old male who was vaccinated 8 days prior to admission (on 26June) to hospital started to have rash appear on body (on chest, upper arms, and thighs). Rash appear small in size and scattered and itchy. Pt admitted for observation to r/o generalized vaccinia. Derm and VIG Pt conferred a mild case. VIG is not indicated. Benadryl 25ml PO ever 6 hours prn, itching.  Nurse follow up on 10/25/04 states: "Final diagnosis confirmed as erythema multiforme minor. Diarrhea was also another symptom."
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Additional Details: Rash/swelling/hives localized to left upper arm lasting approximately 2 weeks. States had same reaction to COVID vaccine previously
Patient came in for Janssen COVID vaccine that was scheduled electronically online.  All appropriate prescreening was done and patient had no previous allergies or issues.  Patient was instructed to sit in one of the chairs designated for post vaccine observation.  Within minutes (less than 3), patient was very dizzy, clammy (cold sweats), pale and said he did not feel right.  I assisted him to a sitting position on the floor from his chair and we were able to ease him back to a lying down position from there with his head on the floor and feet elevated above heart on a chair.  Patient said that the cold floor actually made him feel better instantly.  At 4:18pm after lying down for about 3 minutes we checked his blood pressure with him still lying down.  It was 110/88 and pulse of 104 (so slightly elevated pulse).  He said he was feeling better and we kept him lying down.  Patient's wife was also there so she was able to provide information in addition to him doing it also.  She did state that he occasionally had panic attacks and she thought this might be one, the patient was adamant that it was not.  At 4:24 pm we checked his blood pressure again and it was 100/90 and Pulse of 104.  He was feeling quite a bit better so we had him come to a sitting position on the floor and he had not eaten in a while so we got him a granola bar and water.  Pt slowly ate these and begin to feel clammy and sweaty again within 3-4 minutes. We checked his blood pressure again and it was 104/90 and pulse of 100.  He wanted to stay sitting to see if it would pass.  We did continuously observe injection site and screen for any other symptoms of an allergic reaction (nausea, cramping, swelling, and none of these were occurring). Since he was still not feeling well we gave the patient 50mg of benadryl (20 mls of 12.5mg/5ml liquid benadryl) with his approval. After about 10 minutes of sitting total he was still having cold sweats and feeling dizzy so we had him lie back on his back with his feet elevated while the benadryl kicked in.  By 4:50pm he was feeling well enough to sit back up and we got him some wraps and a coke from the cafe to eat.  Pt continued to consistently improve and was ready to leave about 5:20pm.  We advised him and his wife of signs and symptoms of allergic reaction and to have those treated to immediately at urgent care or and ER.   We also told him to follow-up with his PCP.  I had a manager help walk them to their car.  They were very kind and grateful.  I will follow-up with a call tomorrow and again on Friday to make sure he continues to do well.
Soreness, like a rash on left upper arm. Redness on upper left arm. Took BENADRYL and put ice on arm.
He had the vaccination on 07/15/2022. We noticed the rash on 07/24/2022 on the back of his neck, back and both legs. It progressed the following day and his left eye was swollen and more rash on his upper chest. We gave over the counter ZYRTEC but it doesn't seem to be working. We sent the doctor office a message and waiting to hear back.
29SEP92 recvd flu vax; 1OCT92 c/o pain in chest & arms w/PC to pvt MD; 3OCT92 ER visit-ER MD states was reaction to flu shot;
red marks like that on her arm, 2 by 1 streak across her arm; loss of appetite; fever of 101.3; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red marks like that on her arm, 2 by 1 streak across her arm), DECREASED APPETITE (loss of appetite) and PYREXIA (fever of 101.3) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 062G20A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced ERYTHEMA (red marks like that on her arm, 2 by 1 streak across her arm), DECREASED APPETITE (loss of appetite) and PYREXIA (fever of 101.3). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, ERYTHEMA (red marks like that on her arm, 2 by 1 streak across her arm), DECREASED APPETITE (loss of appetite) and PYREXIA (fever of 101.3) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, Body temperature: 101.3 f High.         Concomitant medications were not provided by the reporter.   This case was linked to MOD-2021-047087.
Wed. 11-18-15 mom noticed nasal passages and area above lips swollen. Mom gave multi-symptom cold/flu with antihistamine med. Thurs 11-19-15 more swelling of lips and (R) side of face. Taken to hospital. Given BENADRYL 2.5 ml (6.25 mg). Fri. 11-20-15 to see local medical provider. Both sides face swollen "puffy" and hands. Given BENADRYL again. No cough, no temp. Did have diarrhea. C/o painful urination.
A large, red, inflamed rash began to develop near the injection site approximately 7.5 days after the injection. The rash burned more so than it itched. It remained very red and inflamed for approximately 36 hours and then began to subside. I did not treat the rash with anything, as it began to improve on its own fairly quickly.
Expired Havrix administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 1-year-old female patient who received HAV (Havrix) (batch number EP47E, expiry date 6th February 2023) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 16th February 2023, the patient received Havrix and Havrix Pre-Filled Syringe Device. On 16th February 2023, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 16-FEB-2023 Reporter's Comment: The reporter called to inquire any information when could revaccinate.  The reporter reported they inadvertently administered an expired Havrix dose to a patient on 16th February 2023.  The reporter did not consent to follow-up. Additional Supportive Information: The patient inadvertently administered an expired Havrix dose, which led to Expired vaccine used.
Patient experienced a severe headache and vomiting approximately 5 hours after vaccination. After that, her regular-spaced monthly periods went completely haywire. One year later, her menses are not back to normal. She recently went to a gynecologist, who ordered an ultrasound on her lower abdomen.
Patient developed a red, swollen, oval, itchy spot at the general area of the injection site.
Nerve pain began 4 days after the flu shot. I began to feel prickling in the hands and feet which turned into intense electric like shocking pain that was in my feet, legs, arms in hands. This pain got worse over the course of 8 weeks. I would feel the stabbing pain about once every 10 minutes.  I then began to have muscle pain and involuntary muscle twitching and muscle fluttering. The pain went on for 4 months and is still continuing although it seems to be getting milder and less frequent.  I have never had this before I received the flu shot.
Patient had red bumps all over body that she believes were hives. She went to a provider who did not know what could have caused it.
Possible delayed reaction to Pfizer first dose resulting in rash and hives that have continued for eleven days (and counting).  Hives appear on all areas of body except site of injection, soles of feet, knees and mid-chest and mid-back areas.  Hives have gradually spread over last four days.
Moderna booster which seems to be from an expired vial it expired 11Oct2021; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna booster which seems to be from an expired vial it expired 11Oct2021) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 1808609) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna booster which seems to be from an expired vial it expired 11Oct2021). On 25-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Moderna booster which seems to be from an expired vial it expired 11Oct2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and Treatment medications was not specified The patient received a first dose of Johnson & Johnson COVID19 Vaccine (lot number 1808609) on 30Mar2021
amyotrophic lateral sclerosis/ severe pain/ full body-wide fasciculations; death; Information has been received regarding a case in litigation from a lawyer and referred to a male patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or around 16-MAY-2014, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (strength, dose, route, lot# and expiration date were not reported). Shortly after receiving zoster vaccine live (ZOSTAVAX), the patient suffered full body-wide fasciculations and amyotrophic lateral sclerosis. As a direct and proximate result of these injuries, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient suffered significant medical expenses, severe pain and suffering, other damages, and ultimately death on 02-FEB-2019. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient suffered serious and dangerous side effects, including death, as well as other severe and personal injuries which were permanent and lasting in nature, physical pain and mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient had suffered and incurred damages, including medical expenses, the loss of accumulations and other economic and non-economic damages. The cause of death was unknown. It was unknown if an autopsy was performed. The outcome of the event amyotrophic lateral sclerosis was considered as not recovered. The causality assessment between the events death and amyotrophic lateral sclerosis and zoster vaccine live (ZOSTAVAX) was considered as related by the lawyer.   The lawyer considered the event amyotrophic lateral sclerosis to be disability. Upon internal review, amyotrophic lateral sclerosis was determined to be medically significant.
Patient fainted a few minutes after vaccination.  Pulse was hard to find.  Once EMS arrived, they suggested transporting him due to the fact a regular pulse could not be obtained.  Patients pulse remained very low.
PROTRACTED VOMITING,  102.4 FEVER~20 HOURS,  DEBILITATING HEAD ACHE x~36 HOURS.   GENERALZED WEAKNESS.   PERSISTENT INTERMITTENT NAUSEA x5+ DAYS.  FAMILY REPORTED RAMBLING SPEECH WHILE SLEEPING.  The headache was reminiscent of the time I had a spinal fluid leak after a lumbar puncture.  BAD!
10/6/17 Seizure at 0300 Temp 99.3 went to neurologist office a few days later.
very sick, day 4 stayed in bed, felt awful.; felt awful; back pain; all her body, in elbow both arm especially and back pain; headaches; super significant joint pain, very painful; fatigue, tiredness; pain and tenderness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt awful), BACK PAIN (back pain), ILLNESS (very sick, day 4 stayed in bed, felt awful.), PAIN (all her body, in elbow both arm especially and back pain) and HEADACHE (headaches) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04SA21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain and tenderness at the injection site). On 19-Mar-2021, the patient experienced BACK PAIN (back pain), PAIN (all her body, in elbow both arm especially and back pain), HEADACHE (headaches), ARTHRALGIA (super significant joint pain, very painful) and FATIGUE (fatigue, tiredness). On 22-Mar-2021, the patient experienced FEELING ABNORMAL (felt awful) and ILLNESS (very sick, day 4 stayed in bed, felt awful.). On 22-Mar-2021, HEADACHE (headaches) and ARTHRALGIA (super significant joint pain, very painful) had resolved. At the time of the report, FEELING ABNORMAL (felt awful), BACK PAIN (back pain), ILLNESS (very sick, day 4 stayed in bed, felt awful.), PAIN (all her body, in elbow both arm especially and back pain) and VACCINATION SITE PAIN (pain and tenderness at the injection site) outcome was unknown and FATIGUE (fatigue, tiredness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications was reported Treatment information was not provided
Around a month and a half after his second dose, patient develops , what he is describing, a form of folliculitis, on his legs, arms and back, describes as being small, itchy, round, inflamed hair follicle, does wear compression socks and sees a therapist/specialist for lymphedema, hx of leg edema
3 weeks post vaccination patient had red indented area size of quarter at site of injection.  Tender to touch and turned bright red after showering. Was not improving and was going to see physician.